Gilead Sciences collaborates with Indian companies to produce affordable generic versions of its HIV prevention therapy, lenacapavir, potentially dropping prices from $40,000 to $200-$300 annually in India. Despite the promise, experts criticize the restrictive voluntary license, which may hinder API supply and delay significant price cuts in developing countries.
HIV prevention therapy likely to become cheaper but accessibility concerns remain
Categories:
Related Post
Apalachee High School shooting in Georgia. What to know.Apalachee High School shooting in Georgia. What to know.
The Georgia Bureau of Investigations says at least four people are dead and at least nine people are injured after a shooting at Apalachee High School in Winder, Georgia, Wednesday.
Bitcoin plunged 28%. Institutional investors bought the dipBitcoin plunged 28%. Institutional investors bought the dip
Spot crypto ETFs show that many investors bought the dip this week.
New York City McDonald’s starts carding teenagers in response to crime: ‘People fight in there’New York City McDonald’s starts carding teenagers in response to crime: ‘People fight in there’
A New York City McDonald’s is now barring groups of teenagers from its restaurant after enduring an influx of delinquent behavior. The location, which is located in Flatbush, Brooklyn, is